129 related articles for article (PubMed ID: 9524088)
1. Vinca-alkaloid neurotoxicity measured using an in vitro model.
Geldof AA; Minneboo A; Heimans JJ
J Neurooncol; 1998 Apr; 37(2):109-13. PubMed ID: 9524088
[TBL] [Abstract][Full Text] [Related]
2. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
Pereira E; Tarasiuk J; Garnier-Suillerot A
Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells.
King KL; Boder GB
Cancer Chemother Pharmacol; 1979; 2(4):239-42. PubMed ID: 455582
[TBL] [Abstract][Full Text] [Related]
5. Effect of thiopental, propofol, and etomidate on vincristine toxicity in PC12 cells.
Lin CR; Cheng JT; Lin FC; Chou AK; Lee TC; Chen JT; Yang LC
Cell Biol Toxicol; 2002; 18(1):63-70. PubMed ID: 11991087
[TBL] [Abstract][Full Text] [Related]
6. Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.
Al-Ahmad A; Kümmerer K
Cancer Detect Prev; 2001; 25(1):102-7. PubMed ID: 11270417
[TBL] [Abstract][Full Text] [Related]
7. Reversal by NGF of cytostatic drug-induced reduction of neurite outgrowth in rat dorsal root ganglia in vitro.
Konings PN; Makkink WK; van Delft AM; Ruigt GS
Brain Res; 1994 Mar; 640(1-2):195-204. PubMed ID: 7911725
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
Jordan MA; Himes RH; Wilson L
Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
[TBL] [Abstract][Full Text] [Related]
9. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.
Verstappen CC; Postma TJ; Geldof AA; Heimans JJ
Anticancer Res; 2004; 24(4):2337-41. PubMed ID: 15330181
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.
Tolis C; Photiou A; Camplejohn RS; Retsas S
Anticancer Res; 1993; 13(1):161-6. PubMed ID: 8476208
[TBL] [Abstract][Full Text] [Related]
11. Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy.
Geldof AA
J Cancer Res Clin Oncol; 1995; 121(11):657-60. PubMed ID: 7593129
[TBL] [Abstract][Full Text] [Related]
12. In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.
Verstappen CC; Geldof AA; Postma TJ; Heimans JJ
J Neurooncol; 1999 Aug; 44(1):1-5. PubMed ID: 10582662
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism.
Hindley S; Juurlink BH; Gysbers JW; Middlemiss PJ; Herman MA; Rathbone MP
J Neurosci Res; 1997 Feb; 47(4):427-39. PubMed ID: 9057136
[TBL] [Abstract][Full Text] [Related]
14. Increased neurite outgrowth of cultured rat dorsal root ganglion cells following transection or inhibition of axonal transport of the sciatic nerve.
White DM; Mansfield K; Kelleher K
Neurosci Lett; 1996 Apr; 208(2):93-6. PubMed ID: 8859898
[TBL] [Abstract][Full Text] [Related]
15. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
16. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells.
Van Belle SJ; De Smet MC; De Mey JE; Storme GA
Anticancer Res; 1991; 11(1):465-71. PubMed ID: 2018383
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro and in vivo effects of vincristine and vindesine on leukemic cells from patients with chronic granulocytic leukemia in blast crisis.
Theodorakis ME; Goldberg J
Leuk Res; 1984; 8(6):1065-71. PubMed ID: 6595480
[TBL] [Abstract][Full Text] [Related]
18. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
Lobert S; Frankfurter A; Correia JJ
Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
[TBL] [Abstract][Full Text] [Related]
19. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
[TBL] [Abstract][Full Text] [Related]
20. Okadaic acid, a protein phosphatase inhibitor, inhibits nerve growth factor-directed neurite outgrowth in PC12 cells.
Chiou JY; Westhead EW
J Neurochem; 1992 Nov; 59(5):1963-6. PubMed ID: 1328535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
